Company Profiles

driven by the PitchBook Platform

Crititech

Description

Manufacturer of fine-particle compounds designed to micronize a wide variety of small-molecule and biotechnology drugs. The company develops fine-particle compounds that utilizes its proprietary CO2 technology to develop and manufacture differentiated drugs and medical devices for the human and animal health markets by optimizing delivery of challenging drug substances which includes potent molecules, poorly soluble compounds and bio-molecules with its ability to simplify formulations.

1997

Founded

PRIVATE

Status

11-50

Employees

Angel

Latest Deal Type

$5.9M

Total Amount Raised

6

Investors

Description

Manufacturer of fine-particle compounds designed to micronize a wide variety of small-molecule and biotechnology drugs. The company develops fine-particle compounds that utilizes its proprietary CO2 technology to develop and manufacture differentiated drugs and medical devices for the human and animal health markets by optimizing delivery of challenging drug substances which includes potent molecules, poorly soluble compounds and bio-molecules with its ability to simplify formulations.

Website:

www.crititech.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Delivery

Primary Office

1849 East 1450 Road Lawrence, KS 66044United States +1 (785) 841-7120
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Crititech's full profile, request a free trial.

    Crititech Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Crititech Investors (6)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    National Institutes of HealthGovernment000 0000000 0000
    Precede FundVenture CapitalMinority000 0000000 0000
    SeedStep AngelsAngel GroupMinority000 0000000 0000
    The TAC GroupCorporationMinority000 0000000 0000
    Tony SchmidtAngel (individual)Minority000 0000000 0000
    National Institutes of Health Government
    Precede Fund Venture Capital
    SeedStep Angels Angel Group
    The TAC Group Corporation
    Tony Schmidt Angel (individual)

    Crititech Executive Team (8)

    NameTitleBoard
    Seat
    Contact
    Info
    Matthew McClorey JDPresident & Board Member
    Jeffrey MorrisonChief Financial Officer
    Sam CampbellChairman, President & Chief Strategy Officer
    Michael Baltezor Ph.DChief Scientific Officer
    Jahna EspinosaDirector, Laboratory Operations
    Matthew McClorey JD President & Board Member
    Jeffrey Morrison Chief Financial Officer
    Sam Campbell Chairman, President & Chief Strategy Officer
    Michael Baltezor Ph.D Chief Scientific Officer
    Jahna Espinosa Director, Laboratory Operations

    Crititech Board Members (4)

    NameRepresentingRoleSinceContact
    Info
    Bala Subramaniam Ph.DCrititechCo-Founder & Board Member000 0000
    Matthew McClorey JDCrititechPresident & Board Member000 0000
    Sam CampbellCrititechChairman, President & Chief Strategy Officer000 0000
    William Duncan Ph.DSelfBoard Member000 0000
    Bala Subramaniam Ph.D Co-Founder & Board Member Crititech
    Matthew McClorey JD President & Board Member Crititech
    Sam Campbell Chairman, President & Chief Strategy Officer Crititech
    William Duncan Ph.D Board Member Self
    Request full access to PitchBook